Schizophrenia
Conditions
Keywords
Psychosis, Quality of life, Mindfulness, Compassion, Self-compassion, Schizophrenia
Brief summary
This is a randomized clinical trial to check whether the quality of life of patients with schizophrenia improves after participation in the mindfulness and self-compassion (MSC) programme.
Detailed description
MAIN AIM To check whether the quality of life of patients with schizophrenia improves after participation in the mindfulness and self-compassion (MSC) programme, compared with those participating in an active control programme or those following usual treatment. DESIGN Randomized clinical trial, three parallel groups: 1. Experimental, which will receive the MSC together with the usual treatment (TAU). 2. Active control, which will receive an alternative programme with cognitive, behavioural and psychoeducational components (CBTG) together with the TAU. 3. Passive control, which will receive the TAU. STUDY DISORDER Schizophrenia. DATA FROM THE INTERVENTION UNDER STUDY Program developed by Kristin Neff and Christopher Germer, after observing in diverse investigations the inverse correlation between levels of self-pity and diverse pathological clinical variables. POPULATION UNDER STUDY Patients from Telde's Mental Health Unit who have been diagnosed with schizophrenia. TOTAL NUMBER OF SUBJECTS 150
Interventions
BEHAVIORALMindful Self-Compassion Program
It is a protocolized training program in mindfulness and self-compassion skills. It has a duration of 8 weekly group sessions of about two hours and 45 minutes and a silent retreat of 4 hours.
BEHAVIORALCognitive Behaviour Therapy Group
It is a control intervention designed for the development of a control group suitable for comparison with experimental groups.
OTHERTreatment as usual
It is variable according to the clinical and personal characteristics of the patient, the most common components will be described.
Sponsors
Gutiérrez-Hernández, ME
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosis of schizohrenia
Exclusion criteria
* Drug addict
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| World Health Organization Quality of Life Instument. WHOQOL-BREF | 15 minutes | Scores from 5 to 130, the higher score the worse outcome. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Self-compassion scale (SCS) | 15 minutes | Scores from 5 to 130, the higher score the worse outcome |
Contacts
Primary ContactMaría Elena F Gutiérrez-Hernández
Outcome results
None listed